Transmedics Group Inc diskutieren
Transmedics Group Inc
WKN: A2PH5P / Symbol: TMDX / Name: Transmedics Group / Aktie / ? /
147,85 €
-1,71 %
TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $95.00 to $110.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at JPMorgan Chase & Co. from $67.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $92.00 to $105.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at JPMorgan Chase & Co. from $87.00 to $105.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $95.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $105.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $120.00 price target on the stock, up previously from $95.00.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at JPMorgan Chase & Co. from $105.00 to $127.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $100.00 to $130.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Stephens. They set an "overweight" rating and a $151.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $161.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at TD Cowen from $130.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $120.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Oppenheimer Holdings Inc. from $125.00 to $200.00. They now have an "outperform" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Piper Sandler from $170.00 to $180.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) had its price target raised by analysts at Stephens from $151.00 to $178.00. They now have an "overweight" rating on the stock.
Ratings data for TMDX provided by MarketBeat
TransMedics Group, Inc. (NASDAQ: TMDX) is now covered by analysts at Needham & Company LLC. They set a "buy" rating and a $208.00 price target on the stock.
Ratings data for TMDX provided by MarketBeat
Neueste Beiträge
Piper_Sandler in Chewy Inc diskutieren